These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25265826)

  • 1. Study of comparative bioavailability of omeprazole pellets.
    Karim S; Hay YK; Baie SH; Bukhari NI; Murtaza G
    Acta Pol Pharm; 2014; 71(3):463-8. PubMed ID: 25265826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and bioequivalence of 20 mg omeprazole capsule in 24 healthy Korean male volunteers.
    Rhim SY; Park JH; Park YS; Lee MH; Hwang KG; Kim YS; Shaw LM; Lee YS; Kang JS
    Int J Clin Pharmacol Ther; 2009 Jan; 47(1):23-9. PubMed ID: 19203529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalence study of two capsule formulations of omeprazole in healthy volunteers.
    Allegrini A; Nuzzo L; Scaringi AT; Felaco S; Pavone D; Toniato E; Mezzetti A; Martinotti S; Lenotti G
    Arzneimittelforschung; 2008; 58(8):385-8. PubMed ID: 18807578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioequivalence and pharmacokinetic study of two different omeprazole capsule formulations in healthy Bangladeshi volunteers.
    Joti JJ; Nahar K; Hasan A; Azad MA; Ullah MA; Islam SM; Hasnat A
    Arzneimittelforschung; 2009; 59(4):171-5. PubMed ID: 19517893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioequivalence assessment of two capsule formulations of omeprazole in healthy volunteers.
    Hussein RF; Lockyer M; Hammami MM
    Arzneimittelforschung; 2007; 57(2):101-5. PubMed ID: 17396620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative bioavailability and pharmacokinetic study of omeprazole 20 mg enteric-coated tablet in healthy Bangladeshi volunteers.
    Hasan A; Abul Kalam Azad M; Ullah MA; Mahbub Latif AH; Hasnat A
    Int J Clin Pharmacol Ther; 2009 Mar; 47(3):215-21. PubMed ID: 19281731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologically Based Biopharmaceutics Modeling for Gefapixant IR Formulation Development and Defining the Bioequivalence Dissolution Safe Space.
    Wang M; Heimbach T; Zhu W; Wu D; Reuter KG; Kesisoglou F
    AAPS J; 2024 Jun; 26(4):69. PubMed ID: 38862807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioequivalence study of two capsule formulations of omeprazole.
    Pillai GK; Salem MS; Najib NM; Jilani J; Hasan MM; Ghanem E; Sallam E; Shubair MS; al-Delq S
    Acta Pharm Hung; 1996 Nov; 66(6):231-5. PubMed ID: 9604487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative bioavailability of two oral formulations of omeprazole.
    Flores-Murrieta FJ; Carrasco-Portugal Mdel C; Reyes-García G; Medina-Santillán R; Herrera JE
    Proc West Pharmacol Soc; 2009; 52():18-20. PubMed ID: 22128412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bioequivalence study of two omeprazole formulations in healthy male volunteers.
    Kim YK; Yoon S; Yu KS; Kim BH; Yim SV
    Int J Clin Pharmacol Ther; 2016 Nov; 54(11):928-934. PubMed ID: 27615007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A relative bioavailability study of 2 oral formulations of omeprazole after their administration in repeated doses to healthy volunteers].
    Richards JP; Gimeno M; Moreland TA; McEwen J
    Gastroenterol Hepatol; 1999 Apr; 22(4):171-5. PubMed ID: 10349786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioequivalence of two lansoprazole delayed release capsules 30 mg in healthy male volunteers under fasting, fed and fasting-applesauce conditions: a partial replicate crossover study design to estimate the pharmacokinetics of highly variable drugs.
    Thota S; Khan SM; Tippabhotla SK; Battula R; Gadiko C; Vobalaboina V
    Drug Res (Stuttg); 2013 Nov; 63(11):551-7. PubMed ID: 23780504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study on the bioequivalence of two formulations of pravastatin. Data from a crossover, randomised, open-label bioequivalence study in healthy volunteers.
    Almeida S; Filipe A; Almeida A; Gich I; Antonijoan R; Puntes M; Barbanoj M; Cruz Caturla M
    Arzneimittelforschung; 2006; 56(2):70-5. PubMed ID: 16572920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing Virtual Bioequivalence and Clinically Relevant Specifications for Omeprazole Enteric-Coated Capsules by Incorporating Dissolution Data in PBPK Modeling.
    Yang R; Lin Y; Chen K; Huang J; Yang S; Yao A; Yang X; Lei D; Xiao J; Yang G; Pei Q
    AAPS J; 2024 Jul; 26(4):82. PubMed ID: 38997548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.
    Rhim SY; Park JH; Park YS; Lee MH; Kim DS; Shaw LM; Yang SC; Kang JS
    Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose relative bioavailability of a new quetiapine fumarate extended-release formulation: a postprandial, randomized, open-label, two-period crossover study in healthy Uruguayan volunteers.
    Estevez-Carrizo FE; Parrillo S; Ercoli MC; Estevez-Parrillo FT
    Clin Ther; 2011 Jun; 33(6):738-45. PubMed ID: 21704238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative bioavailability and pharmacokinetic properties of two different enteric formulations of esomeprazole in healthy Bangladeshi male volunteers: An open-label, single-dose, randomized-sequence, two-way crossover study.
    Ullah MA; Shams-Ud-Dowla ; Maruf AA; Azad MA; Shohag MH; Sultana R; Latif AH; Hasnat A
    Clin Ther; 2010 Jul; 32(7):1419-26. PubMed ID: 20678688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative bioavailability of 2 tablet formulations of levodopa/benserazide in healthy, fasting volunteers: a single-dose, randomized-sequence, open-label crossover study.
    Keller GA; Czerniuk P; Bertuola R; Spatz JG; Assefi AR; Di Girolamo G
    Clin Ther; 2011 Apr; 33(4):500-10. PubMed ID: 21635995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative bioavailability of two enteric-coated capsules of omeprazole in healthy volunteers.
    Garg SK; Chugh Y; Tripathi SK; Kumar N; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1993 Feb; 31(2):96-9. PubMed ID: 8458683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.